Diagnostic Efficiency of a Point-of-Care System for Quantitative Determination of Troponin T and Myoglobin in the Coronary Care Unit

Plastic Surgical Nursing

Volumn 3, Issue 4, 2004, Pages 162-164

  Hirschl, Michael M ^a   Derhaschnig, Ulla ^a   Collinson, Paul O ^b   Gaze, David ^b   Haass, Markus ^c   Katus, Hugo A ^d   Chwallek, Frank ^d   Mueller Bardorff, Margit ^e   Kellett, John ^f   Ordóñez Llanos, Jordi ^g   Mercé Muntañola, Javier ^g   Santaló Bell, Miquel ^g   Sylvén, Christer ^h   Schulz, Ilse ⁱ   Zerback, Rainer ⁱ  

^a UNIVERSITY OF VIENNA   (Austria)

^b ST GEORGE S HOSPITAL   (United Kingdom)

^c St Hedwig Klinik GmbH   (Germany)

^d UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^e UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^f St Joseph's General Hospital Nenagh   (Ireland)

^g HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^h KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

ⁱ ROCHE DIAGNOSTICS GMBH   (Germany)

Author keywords

acute myocardial infarction; cardiac markers; myoglobin; point of care testing; troponin T

Indexed keywords

EID: 85026161127     PISSN: 07415206     EISSN: 15501841     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Bertrand ME, Simoons ML, Fox KA, et al. Management of acute coronary syndromes: acute coronary syndromes without persistent ST segment elevation: recommendations of the Task Force of the European Society of Cardiology. Eur Heart J. 2000;21:1406-1432.
2. Braunwald E, Antman EM, Beasley JW, et al. ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: executive summary and recommendations: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina). Circulation. 2000;102:1193-1209.
3. The Joint European Society of Cardiology/American College of Cardiology Committee. Myocardial infarction redefined-a consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction. Eur Heart J. 2000;21:1502-1513.
4. Jórgensen B, Pedersen V, Mahdi A, et al. Evaluation of a portable instrument for measurement of cTnT and myoglobin. Scand J Clin Lab Invest. 1998;58(suppl):228.
5. Mueller-Bardorff M, Sylvén C, Rasmanis G, et al. Evaluation of a point-of-care system for quantitative determination of troponin T and myoglobin. Clin Chem Lab Med. 2000;38:567-574.
6. Collinson PO, Jórgensen B, Sylvé;n C, et al. Recalibration of the point-of-care test for Cardiac T Quantitative with Elecsys Troponin T 3rd Generation. Clin Chim Acta. 2001;307:197-203.
7. Lee-Lewandrowski E, Lewandrowski K. Evaluation of the Roche troponin T cardiac reader in an emergency department STAT laboratory. Comparison to the Elecsys troponin T method. Point of Care. 2002;1:78-83.
8. Goldmann BU, Langenbrink L, Matschuck G, et al. Quantitative bedside testing of troponin T: is it equal to laboratory testing? The cardiac reader troponin T (CARE T) study. Clin Lab. 2004;50:1-10.
9. Panteghini M, Pagani F, Bonetti G. The sensitivity of cardiac markers: an evidence-based approach. Clin Chem Lab Med. 1999;37:1097-1106.
10. Agewall S. Evaluation of point-of-care test systems using the new definition of myocardial infarction. Clin Biochem. 2003;36:27-30.